Evidence map›Paper›PMID 42395059›Full record

ArticleRegenerative therapy2026

Jiyoung Lee, Hiroshi Matsukawa, Kohei Sawada, Rin Kaneko, Fumitoshi Ishino

Abstract read
In one paragraph

Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiyoung LeeInstitute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, 113-8510, Japan.
Hiroshi MatsukawaHigashimatsuyama Laboratories for In Vitro Science, Drug Safety Testing Center Co., Ltd, Saitama, 355-0071, Japan.
Kohei SawadaThe University of Tokyo, Tokyo, 113-0033, Japan.
Rin KanekoDepartment of Developmental and Regenerative Biology, Medical Research Institute, TMDU, Tokyo, 113-8510, Japan.
Fumitoshi IshinoInstitute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, 113-8510, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Recently, methods for Methods: In the present study, we optimized the culturing method of human heart organoids (hHOs) from human embryonic stem cells (hESCs) in the presence of the highly concentrated laminin-entactin and fibroblast growth factor 4 by the supplementation of BMP4, BMP10 and ROCK inhibitor (Y27632). Results: The resulting hHOs showed distinctive cardiac morphology with atrium- and ventricle-like chambers composed of cardiac cells, smooth muscle and endothelial cells as well as expressed the integral proteins of gap junctions like Connexin 40 (Cx40), Cx43 and Cx45, and ion channel proteins including K Conclusions: These results indicate that hHOs generated in this study retain physiological cardiac functions, as they recapitulate

Indexed as

Cardiac ion channelsHuman ESCsHuman heart organoidsPatch clamp analysis

Identifiers

PMID42395059
PMCPMC13324305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.